SV Health Investors Home Page
← Back to Team

Dominic Walsh

Biogen

Dominic Walsh joined Biogen in September 2018 and is the head of the Alzheimer’s Disease & Dementia Research Unit (ADRU). He is responsible for overseeing Biogen’s research and early development efforts on AD and dementia.

Dominic has worked on the molecular pathology of AD since December 1991. He has authored over 150 research articles and written a number of widely cited reviews, and given over 100 invited lectures and webinars. He has served as an Editor or Editorial Advisor for several journals and as an ad hoc reviewer for all of the world’s leading biomedical journals. Dominic has also served as a consultant and/or SAB member for several pharmaceutical companies and biotechs.

Prior to joining Biogen his research was supported by multiple agencies, grants from industry and donations from the general public. In 2014, 2015, 2016 and 2017 he was named one of The World’s Most Influential Scientific Minds by Thomson Reuters and ranked among the top 1% of researchers in the field of Neuroscience and Behaviour.